Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

被引：30

作者：

Cohen, Adam D. ^{[1
]}

Landau, Heather ^{[2
]}

Scott, Emma C. ^{[3
]}

Liedtke, Michaela ^{[4
]}

Kaufman, Jonathan L. ^{[5
]}

Rosenzweig, Michael ^{[6
]}

Gasparetto, Cristina ^{[7
]}

Vesole, David H. ^{[8
]}

Sanchorawala, Vaishali ^{[9
]}

Lentzsch, Suzanne ^{[10
]}

Gomes, Christina L. ^{[11
]}

Comenzo, Raymond L. ^{[12
]}

Durie, Brian G. M. ^{[13
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, Myeloma Serv, New York, NY 10021 USA

[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[4] Stanford Canc Inst, Stanford, CA USA

[5] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[6] City Hope Natl Med Ctr, Judy & Bernard Briskin Myeloma Ctr, Duarte, CA USA

[7] Duke Univ, Med Ctr, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27705 USA

[8] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[9] Boston Med Ctr, Boston, MA USA

[10] Columbia Univ, Div Hematol Oncol, Med Ctr, New York, NY 10025 USA

[11] Criterium Inc AMyC, Saratoga Springs, NY USA

[12] Tufts Med Ctr, Boston, MA USA

[13] Cedars Sinai Outpatient Canc Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA

来源：

关键词：

D O I：

10.1182/blood.V128.22.645.645

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

645

引用

页数：5